↓ Skip to main content

Cochrane Database of Systematic Reviews

Combined psychotherapy plus antidepressants for panic disorder with or without agoraphobia

Overview of attention for article published in Cochrane database of systematic reviews, January 2007
Altmetric Badge

About this Attention Score

  • Good Attention Score compared to outputs of the same age (75th percentile)
  • Average Attention Score compared to outputs of the same age and source

Mentioned by

policy
1 policy source
twitter
2 tweeters
facebook
2 Facebook pages

Citations

dimensions_citation
114 Dimensions

Readers on

mendeley
186 Mendeley
connotea
1 Connotea
Title
Combined psychotherapy plus antidepressants for panic disorder with or without agoraphobia
Published in
Cochrane database of systematic reviews, January 2007
DOI 10.1002/14651858.cd004364.pub2
Pubmed ID
Authors

Toshi A Furukawa, Norio Watanabe, Rachel Churchill

Abstract

Panic disorder can be treated with pharmacotherapy, psychotherapy or in combination, but the relative merits of combined therapy have not been well established.

Twitter Demographics

The data shown below were collected from the profiles of 2 tweeters who shared this research output. Click here to find out more about how the information was compiled.

Mendeley readers

The data shown below were compiled from readership statistics for 186 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Germany 2 1%
United Kingdom 1 <1%
Ireland 1 <1%
Netherlands 1 <1%
Canada 1 <1%
China 1 <1%
Japan 1 <1%
United States 1 <1%
Unknown 177 95%

Demographic breakdown

Readers by professional status Count As %
Student > Master 29 16%
Researcher 25 13%
Student > Ph. D. Student 21 11%
Student > Bachelor 19 10%
Student > Postgraduate 15 8%
Other 44 24%
Unknown 33 18%
Readers by discipline Count As %
Medicine and Dentistry 65 35%
Psychology 46 25%
Nursing and Health Professions 7 4%
Agricultural and Biological Sciences 6 3%
Pharmacology, Toxicology and Pharmaceutical Science 5 3%
Other 17 9%
Unknown 40 22%

Attention Score in Context

This research output has an Altmetric Attention Score of 5. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 17 July 2016.
All research outputs
#4,667,012
of 17,359,532 outputs
Outputs from Cochrane database of systematic reviews
#7,062
of 11,660 outputs
Outputs of similar age
#62,077
of 255,372 outputs
Outputs of similar age from Cochrane database of systematic reviews
#314
of 472 outputs
Altmetric has tracked 17,359,532 research outputs across all sources so far. This one has received more attention than most of these and is in the 72nd percentile.
So far Altmetric has tracked 11,660 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 25.0. This one is in the 38th percentile – i.e., 38% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 255,372 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 75% of its contemporaries.
We're also able to compare this research output to 472 others from the same source and published within six weeks on either side of this one. This one is in the 33rd percentile – i.e., 33% of its contemporaries scored the same or lower than it.